VW’s Audi says November sales up 11 percent to record 146,250 cars
BERLIN (Reuters) – Audi increased sales of luxury cars 11 percent in November to 146,250 vehicles, its best-ever result for that month, bolstered by double-digit growth in the United States and China.
Deutsche tests investor patience with no-surrender strategy
FRANKFURT (Reuters) – Deutsche Bank’s determination to be the last European in the upper echelons of global investment banking is an expensive waiting game for investors.
Mazda says U.S. recalls over Takata air bags to be expanded nationwide
TOKYO (Reuters) – Mazda Motor Corp will soon expand a recall of vehicles in the United States involving potentially defective air bags by Takata Corp , a spokeswoman said on Tuesday.
Lufthansa November passenger sales rise, Austrian hit by Ukraine crisis
BERLIN (Reuters) – Germany’s Lufthansa reported a 2.4 percent rise in sales at its passenger business for November but said that its unit Austrian Airlines was being hit by the crisis in Russia and Ukraine.
Oil hits five-year low, crushing risk appetite
LONDON (Reuters) – Oil prices plumbed fresh five-year lows on Tuesday, prompting investors worried about the global economy and renewed political uncertainty in Greece to dump shares.
German carmakers unveil surprise changes in top management
FRANKFURT/BERLIN (Reuters) – In a surprise move, BMW said on Tuesday its long-time chief executive Norbert Reithofer would step down in May, one year early, and hand the reins of the Munich-based luxury carmaker to 49-year-old production chief Harald K…
Honda to expand investigative air bag recall globally
TOKYO (Reuters) – Honda Motor said it will expand an ‘investigative’ recall to replace potentially lethal Takata Corp air bag inflators across the globe, taking the total Takata-related recall tally of all brands to more than 19 million since 2008.
Boeing sees aircraft funding market remaining strong
LONDON (Reuters) – Boeing Co forecast continued strong demand for aircraft funding, with commercial jet buyers using capital markets to fund a third of the $124 billion of the sales expected in 2015, the company said on Tuesday.
Merck to take on superbugs with Cubist Pharma buy
(Reuters) – Merck & Co Inc said it would buy Cubist Pharmaceuticals Inc for $8.4 billion plus assumption of debt, giving the major drugmaker an entry into the market for drugs that combat so-called superbugs.
Exclusive: Valeant to drop deal-making in near term to cut debt, boost stock
NEW YORK/WINNIPEG (Reuters) – Valeant Pharmaceuticals International Inc is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and one day return to its traditional deal-making in a stronger po…
